Indian Drugmakers Target Niche Markets

Tuesday, April 19, 2016

Source: The Wall Street Journal

NEW DELHI—India’s leading pharmaceutical companies, which have grown to dominate the generic-drug market, are hoping to squeeze billions in additional sales out of gaps in the U.S. market by developing niche treatments for ailments ignored by industry leaders.

View All News »